SKr 800 million for development of biotech firms
Thursday 19 October, 2017

SKr 800 million for development of biotech firms

Published On: Tue, Feb 20th, 2007 | Science Policy | By BioNews

Karolinska Institutet´s innovations system for the commercialisation of medical discoveries is unique in the world. We have now accumulated a total of 800 million kronor for corporate development in the biotech field. As building starts on the Karolinska Institutet Science Park in Solna, we invite the press to a conference to present our plans for the future.

“In just the space of a few years, our innovations system has generated scores of new small companies,” says University Director Rune Fransson. “Eventually, we expect to be able to create hundreds of new jobs. The construction of Karolinska Institutet Science Park is the next stage in the development of our innovations system.”

The new research park will be built next door to the university campus in Solna. If all goes according to plan, the three oval-shaped buildings, which have been commissioned by Akademiska Hus and which will offer new biotech companies premises boasting ultra-modern infrastructure, will be ready for use in the autumn of 2009. Novum Research Park in Flemingsberg has also joined the innovations system.

“Our units in north and south Stockholm will cooperate closely and benefit from each other,” says Mr Fransson. “We also work alongside other universities in Sweden and the rest of the Nordic region, where several start-ups in the Life Sciences are growing with our support.”

Related Links:
Karolinska Institute

More from Science Policy
  • Science education poor in Myanmar: Suu Kyi
  • Misconduct, Not Error, Accounts For Most Scientific Paper Retractions
  • China, ASEAN seek science cooperation
  • Even Nobel Prize-winning ideas take a long time to get accepted, finds study
  • India to double expenditure on science research